| P50 | author | Isabelle Borget | Q57314970 |
| P2093 | author name string | Maryse Brassard | |
| | Martin Schlumberger | |
| | Sophie Leboulleux | |
| | Camila Nascimento | |
| P2860 | cites work | Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer | Q28262641 |
| | Papillary thyroid carcinoma managed at the Mayo Clinic during six decades (1940-1999): temporal trends in initial therapy and long-term outcome in 2444 consecutively treated patients | Q34523261 |
| | Disappearance of humoral thyroid autoimmunity after complete removal of thyroid antigens | Q35215882 |
| | European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium | Q36489842 |
| | Follow up approaches in thyroid cancer: a risk adapted paradigm | Q37172777 |
| | Persistent disease and recurrence in differentiated thyroid cancer patients with undetectable postoperative stimulated thyroglobulin level. | Q37823794 |
| | Serum Basal thyroglobulin measured by a second-generation assay correlates with the recombinant human thyrotropin-stimulated thyroglobulin response in patients treated for differentiated thyroid cancer | Q42471489 |
| | Risk-adapted management of differentiated thyroid cancer assessed by a sensitive measurement of basal serum thyroglobulin. | Q42486055 |
| | Efficacy of preoperative neck ultrasound in the detection of cervical lymph node metastasis from thyroid cancer | Q46261300 |
| | Predictive value for disease progression of serum thyroglobulin levels measured in the postoperative period and after (131)I ablation therapy in patients with differentiated thyroid cancer. | Q47386305 |
| | Application of post-surgical stimulated thyroglobulin for radioiodine remnant ablation selection in low-risk papillary thyroid carcinoma. | Q51718288 |
| | Serum Thyroglobulin Levels at the Time of131I Remnant Ablation Just after Thyroidectomy Are Useful for Early Prediction of Clinical Recurrence in Low-Risk Patients with Differentiated Thyroid Carcinoma | Q57762283 |
| | Prognostic value of thyroglobulin after thyroidectomy before ablative radioiodine therapy in thyroid cancer | Q71907483 |
| | Positive predictive value of serum thyroglobulin levels, measured during the first year of follow-up after thyroid hormone withdrawal, in thyroid cancer patients | Q73106396 |
| | Monitoring thyroglobulin in a sensitive immunoassay has comparable sensitivity to recombinant human tsh-stimulated thyroglobulin in follow-up of thyroid cancer patients | Q79319487 |
| | Comparison of seven serum thyroglobulin assays in the follow-up of papillary and follicular thyroid cancer patients | Q80140160 |
| | Clinical relevance of highly sensitive Tg assay in monitoring patients treated for differentiated thyroid cancer | Q80445210 |
| | Ultrasound criteria of malignancy for cervical lymph nodes in patients followed up for differentiated thyroid cancer | Q80563906 |
| | Does a highly sensitive thyroglobulin (Tg) assay change the clinical management of low-risk patients with thyroid cancer with Tg on T4 < 1 ng/ml determined by traditional assays? | Q81238595 |
| | Radioiodine therapy in patients with stage I differentiated thyroid cancer | Q82331530 |
| | Prophylactic lymph node dissection for papillary thyroid cancer less than 2 cm: implications for radioiodine treatment | Q83129859 |
| | Long-term follow-up of patients with papillary and follicular thyroid cancer: a prospective study on 715 patients | Q83573612 |
| | Identification and optimal postsurgical follow-up of patients with very low-risk papillary thyroid microcarcinomas | Q84595437 |
| | Lack of association between urinary iodine excretion and successful thyroid ablation in thyroid cancer patients | Q84786011 |
| | Value of Postoperative Thyroglobulin and Ultrasonography for the Indication of Ablation and131I Activity in Patients with Thyroid Cancer and Low Risk of Recurrence | Q85211684 |
| P433 | issue | 10 | |
| P921 | main subject | thyroid cancer | Q826522 |
| P304 | page(s) | 625-628 | |
| P577 | publication date | 2011-08-09 | |
| P1433 | published in | Nature Reviews Endocrinology | Q2079257 |
| P1476 | title | Treatment and follow-up of low-risk patients with thyroid cancer | |
| P478 | volume | 7 | |